Equipe 1

Transcription

Equipe 1
PUBLICATIONS 2011 CPTP Equipe 1 : Tolérance et Autoimmunité (PI : Joost van Meerwijk) 1)Pasquet, L., Joffre, O., Santolaria, T., and van Meerwijk, J.P.M. (2011). Hematopoietic chimerism and transplantation tolerance: a role for regulatory T cells. Frontiers in Immunology in press. 2) Pomié C, Vicente R, Vuddamalay Y, Lundgren BA, van der Hoek M, Enault G, Kagan J, Fazilleau N, Scott HS, Romagnoli P, van Meerwijk JPM. Autoimmune regulator (AIRE)‐
deficient CD8+CD28low regulatory T lymphocytes fail to control experimental colitis. Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12437‐42. Epub 2011 Jul 11. 3) Nouzé C, Pasquet L, van Meerwijk JPM. In vitro expansion of alloantigen‐specific regulatory T cells and their use in prevention of allograft rejection. Methods Mol Biol. 2011;707:187‐96. Equipe 2 : Dynamique et Moléculaire des Interactions Lymphocytaires (PI : Salvatore Valittuti) 1) Laurent C, Müller S, Do C, Al‐Saati T, Allart S, Larocca LM, Hohaus S, Duchez S, Quillet‐Mary A, Laurent G, Brousset P, Valitutti S. Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3‐D tissue‐imaging study. Blood. 2011 Nov 17;118(20):5371‐9. Epub 2011 Aug 19. 2) Sanchez‐Ruiz Y, Valitutti S, Dupre L. Stepwise Maturation of Lytic Granules during Differentiation and Activation of Human CD8 T Lymphocytes. PLoS One. 2011;6(11):e27057. Epub 2011 Nov 4. 3) Duchez S, Rodrigues M, Bertrand F, Valitutti S. Reciprocal polarization of T and B cells at the immunological synapse. J Immunol. 2011 Nov 1;187(9):4571‐80. Epub 2011 Sep 19. 4) Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupré L. The Wiskott‐Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T‐cell receptor signaling. Haematologica. 2011 Oct;96(10):1415‐23. Epub 2011 Jun 9 Equipe 3 : Oestrogenes et cannaux calciques dans la physiopathologie des maladies auto‐immun (PI : Jean Charles Guéry et Lucette Pelletier) 1) Seillet C, Laffont S, Trémollières F, Rouquié N, Ribot C, Arnal JF, Douin‐Echinard V, Gourdy P, Guéry JC The TLR‐mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell‐intrinsic estrogen receptor α‐signaling. Blood. 2011 Nov 16. [Epub ahead of print] 2) Lélu K, Laffont S, Delpy L, Paulet PE, Périnat T, Tschanz SA, Pelletier L, Engelhardt B, Guéry JC. Estrogen receptor α signaling in T lymphocytes is required for estradiol‐mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol. 2011 Sep 1;187(5):2386‐93. Epub 2011 Aug 1. 3) Douin‐Echinard V, Calippe B, Billon‐Galès A, Fontaine C, Lenfant F, Trémollières F, Bayard F, Guéry JC, Arnal JF, Gourdy P. Estradiol administration controls eosinophilia through estrogen receptor‐alpha activation during acute peritoneal inflammation. J Leukoc Biol. 2011 Jul;90(1):145‐54. Epub 2011 Apr 15. 4) Robert V, Triffaux E, Savignac M, Pelletier L. Calcium signalling in T‐lymphocytes. Biochimie. 2011 Dec;93(12):2087‐94. Epub 2011 Jun 21. Equipe 4 : Différenciation des lymphocytes et auto‐immunité ( PI : Sylvie Guerder) 1)S. Guerder, C. Viret, H. Luche, L. Ardouin , B. Malissen. Differential processing of self‐antigens by subsets of thymic stromal cells. Curr. Opin. Immunol. (In press). 2) Viret C, Leung‐Theung‐Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S. Thymus‐specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J Clin Invest. 2011 May 2;121(5):1810‐21. doi: 10.1172/JCI43314. Epub 2011 Apr 18. 3) Viret C, Lamare C, Guiraud M, Fazilleau N, Bour A, Malissen B, Carrier A, Guerder S. Thymus‐
specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire. J Exp Med. 2011 Jan 17;208(1):3‐11. Epub 2010 Dec 20. Equipe 5 : Les maladies inflammatoires du système nerveux : mécanismes et traitement (PI : Roland Liblau et Abdelhadi Saoudi) 1) Chabod M, Pedros C, Lamouroux L, Colacios C, Bernard I, Lagrange D, Balz‐Hara D, Mosnier JF, Laboisse C, Vergnolle N, Andreoletti O, Liblau RS, Saoudi A, Fournié GJ, Dejean AS. A Spontaneous Mutation of the Rat Themis Gene Leads to Impaired Function of Regulatory T Cells Linked to Inflammatory Bowel Disease. PLoS Genet. 2011 In press. 2) Saxena A, Martin‐Blondel G, Mars LT, Liblau RS. Role of CD8 T cell subsets in the pathogenesis of multiple sclerosis. FEBS Lett. 2011 Dec 1;585(23):3758‐63. Epub 2011 Sep 8. 3) Chevalier G, Suberbielle E, Monnet C, Duplan V, Martin‐Blondel G, Farrugia F, Le Masson G, Liblau R, Gonzalez‐Dunia D. Neurons are MHC Class I‐Dependent Targets for CD8 T Cells upon Neurotropic Viral Infection. PLoS Pathog. 2011 Nov;7(11):e1002393. Epub 2011 Nov 17. 4) Colacios C, Casemayou A, Dejean AS, Gaits‐Iacovoni F, Pedros C, Bernard I, Lagrange D, Deckert M, Lamouroux L, Jagodic M, Olsson T, Liblau RS, Fournié GJ, Saoudi A. The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development. J Exp Med. 2011 Oct 24;208(11):2183‐91. Epub 2011 Sep 26. 5) Malhotra S, Morcillo‐Suárez C, Brassat D, Goertsches R, Lechner‐Scott J, Urcelay E, Fernández O, Drulovic J, García‐Merino A, Martinelli Boneschi F, Chan A, Vandenbroeck K, Navarro A, Bustamante MF, Río J, Akkad DA, Giacalone G, Sánchez AJ, Leyva L, Alvarez‐Lafuente R, Zettl UK, Oksenberg J, Montalban X, Comabella M. IL28B polymorphisms are not associated with the response to interferon‐beta in multiple sclerosis. J Neuroimmunol. 2011 Oct 28;239(1‐2):101‐4. Epub 2011 Sep 1.
6) Iscache AL, Ménoret S, Tesson L, Rémy S, Usal C, Pedros C, Saoudi A, Buelow R, Anegon I. Effects of BCL‐2 over‐expression on B cells in transgenic rats and rat hybridomas. Int Immunol. 2011 Oct;23(10):625‐36. Epub 2011 Sep 19. 7) International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Boneschi FM, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget‐Darpoux F, Clysters K, Comi G, Cossburn M, Cournu‐Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante‐Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner‐Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms‐Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak‐Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A. Genetic risk and a primary role for cell‐mediated immune mechanisms in multiple sclerosis. Nature. 2011 Aug 10;476(7359):214‐9. doi: 10.1038/nature10251. 8) Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P, Debouverie M, de Seze J, Wiertlevsky S, Heinzlef O, Tourbah A, Fromont A, Frenay M. Cancer and multiple sclerosis in the era of disease‐modifying treatments. J Neurol. 2011 Jul;258(7):1304‐11. Epub 2011 Feb 4. 9) Collongues N, Marignier R, Zéphir H, Blanc F, Vukusic S, Outteryck O, Fleury M, Ruet A, Borgel F, Thouvenot E, Moreau T, Defer G, Derache N, Pelletier J, Audoin B, Debouverie M, Labauge P, Gout O, Camu W, Brassat D, Brochet B, Vermersch P, Confavreux C, de Seze J. High‐risk syndrome for neuromyelitis optica: a descriptive and comparative study. Mult Scler. 2011 Jun;17(6):720‐4. Epub 2011 Jan 14. 10) Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun‐Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu‐Rebeix I, Goertsches RH, Zettl UK, Comabella M, Montalban X, Rieckmann P, Weber F, Müller‐Myhsok B, Edan G, Fontaine B, Mars LT, Saoudi A, Oksenberg JR, Clanet M, Liblau RS, Brassat D. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain. 2011 Mar;134(Pt 3):693‐703 11) Martin‐Blondel G, Delobel P, Blancher A, Massip P, Marchou B, Liblau RS, Mars LT. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain. 2011 Apr;134(Pt 4):928‐46. Epub 2011 Jan 18. Review. 12) Mars LT, Saikali P, Liblau RS, Arbour N. Contribution of CD8 T lymphocytes to the immuno‐
pathogenesis of multiple sclerosis and its animal models. Biochim Biophys Acta. 2011 Feb;1812(2):151‐61. Epub 2010 Jul 15. Review. 13) Witola WH, Mui E, Hargrave A, Liu S, Hypolite M, Montpetit A, Cavailles P, Bisanz C, Cesbron‐
Delauw MF, Fournié GJ, McLeod R. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii‐infected monocytic cells. Infect Immun. 2011 Feb;79(2):756‐66. Epub 2010 Nov 22. 14) Dejean AS, Hedrick SM, Kerdiles YM. Highly specialized role of Forkhead box O transcription factors in the immune system. Antioxid Redox Signal. 2011 Feb 15;14(4):663‐74. Epub 2010 Dec 13. Review.
15) Affaticati P, Mignen O, Jambou F, Potier MC, Klingel‐Schmitt I, Degrouard J, Peineau S, Gouadon E, Collingridge GL, Liblau R, Capiod T, Cohen‐Kaminsky S. Sustained calcium signalling and caspase‐3 activation involve NMDA receptors in thymocytes in contact with dendritic cells. Cell Death Differ. 2011 Jan;18(1):99‐108. Epub 2010 Jun 25. Equipe 6 : Immunité, gestation et thérapeutique (PI : Philippe le Bouteiller) 1) Le Bouteiller P, Tabiasco J, Giustiniani J & Bensussan A. Nouvelle thérapie anti‐angiogénqiue indépendante du VEGF et ciblant le récepteur CD160. Médecine Sciences, in press 2) Giustiniani J, Alaoui SS, Marie‐Cardine A, Bernard J, Olive D, Bos C, Razafindratsita A, Petropoulou A, Peffault de Latour R, Le Bouteiller P, Bagot M, Socié G, and Bensussan A. Possible pathogenic role of the transmembrane isoform of CD160 NK lymphocyte receptor in paroxysmal nocturnal hemoglobinuria. Current Molecular Medicine, in press 3) Zagorac GB, Mahmutefendić H, Tomaš MI, Kučić N, Le Bouteiller P, Lučin P. Early endosomal rerouting of major histocompatibility class I conformers. J Cell Physiol. 2011 Sep 29. doi: 10.1002/jcp.23042. [Epub ahead of print] 4) Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, Berrebi A, Aguerre‐Girr M, Bensussan A, Jabrane‐Ferrat N. CD160: a unique activating NK cell receptor. Immunol Lett. 2011 Aug 30;138(2):93‐6. Epub 2011 Feb 13. 5) Chabot S, Jabrane‐Ferrat N, Bigot K, Tabiasco J, Provost A, Golzio M, Noman MZ, Giustiniani J, Bellard E, Brayer S, Aguerre‐Girr M, Meggetto F, Giuriato S, Malecaze F, Galiacy S, Jaïs JP, Chose O, Kadouche J, Chouaib S, Teissié J, Abitbol M, Bensussan A, Le Bouteiller P. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med. 2011 May 9;208(5):973‐86. Epub 2011 Apr 11. 6) Le Bouteiller P, Siewiera J, Casart Y, Aguerre‐Girr M, El Costa H, Berrebi A, Tabiasco J, Jabrane‐
Ferrat N. (2011) Human decidual NK‐cell response to virus infection: what can we learn from circulating NK lymphocytes? J. Reprod. Immunol., 88: 170‐175 7) Le Bouteiller P, Siewiera J & Jabrane‐Ferrat N. (2011) Entre mère et fœtus, un dialogue…immunologique. Biofutur, 324 : 37‐40 Equipe 7 : Médiateurs de l’inflammation et de la douleur (PI : Nathalie Vergnolle) 1) De Nadai Souza, A., Muscara, M.N., Vergnolle, N., Cenac, N. “Role of transcient receptor potential vanilloid 4 in joint inflammation” Arthr. Rhum. (In Press) 2) Chabot, M., Pedros, C., Annalma, L., Colacios, C., Bernard, I., Lagrange, D., Balz‐Hara, D., Mosnier, J.F., Laboisse, C., Vergnolle, N., Andreoletti, O., Roth, M.P., Liblau, R., Fournie, G., Dejean, A. “A Spontaneous Mutation of the Rat Themis Gene Leads to Impaired Function of Regulatory T Cells Linked to Inflammatory Bowel Disease” Plos Genetics (In Press) 3) Boue, J., Blanpied, C., Djata‐Cabral, M., Pelletier, L., Vergnolle, N., Dietrich, G. Immune conditions associated with CD4+ T effector‐induced opioid release and analgesia Pain (In Press) 4) Gobbetti, T., Cenac, N., Motta, J.P., Rolland, C., Barocelli, E. Vergnolle N.Inflammatory proteases released in a mouse model of intestinal ischemia Inflamm. Res. 2011, 60: S295‐S297. 5) Ibeakanma C, Ochoa‐Cortes F, Miranda‐Morales M, McDonald T, Spreadbury I, Cenac N, Cattaruzza F, Hurlbut D, Vanner S, Bunnett N, Vergnolle N, Vanner S. Brain‐gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology. 2011 Dec;141(6):2098‐2108.e5. Epub 2011 Aug 19. 6) Gobbetti T, Cenac N, Motta JP, Rolland C, Martin L, Andrade‐Gordon P, Steinhoff M, Barocelli E, Vergnolle N. Serine Protease Inhibition Reduces Post‐Ischemic Granulocyte Recruitment in Mouse Intestine. Am J Pathol. 2011 Nov 7. [Epub ahead of print] 7) Hyun E, Ramachandran R, Hollenberg MD, Vergnolle N. Mechanisms behind the anti‐inflammatory actions of insulin. Crit Rev Immunol. 2011;31(4):307‐40. 8) Lacroix M, Lacaze‐Buzy L, Furio L, Tron E, Valari M, Van der Wier G, Bodemer C, Bygum A, Bursztejn AC, Gaitanis G, Paradisi M, Stratigos A, Weibel L, Deraison C, Hovnanian A. Clinical Expression and New SPINK5 Splicing Defects in Netherton Syndrome: Unmasking a Frequent Founder Synonymous Mutation and Unconventional Intronic Mutations. J Invest Dermatol. 2011 Nov 17;. [Epub ahead of print] PMID: 22089833 9) Andrews CN, Griffiths TA, Kaufman J, Vergnolle N, Surette MG, Rioux KP. Mesalazine (5‐
aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea‐
predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2011 Aug;34(3):374‐83. doi: 10.1111/j.1365‐2036.2011.04732.x. Epub 2011 Jun 14. 10) Fanny Nehmé‐Pelluard, Céline Deraison, Pierre Dubus Elastase 2A: a new player in skin barrier function Expert Review of Dermatology, Aug 2011, Vol. 6, No. 4, Pages 337‐339. 11) Bertrand J, Despeaux M, Joly S, Bourogaa E, Gallay N, Demur C, Bonnevialle P, Louache F, Maguer‐Satta V, Vergnolle N, Payrastre B, Racaud‐Sultan C. Sex differences in the GSK3β‐mediated survival of adherent leukemic progenitors. Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.258. [Epub ahead of print] 12) Shpacovitch VM, Feld M, Holzinger D, Kido M, Hollenberg MD, Levi‐Schaffer F, Vergnolle N, Ludwig S, Roth J, Luger T, Steinhoff M. Role of proteinase‐activated receptor‐2 in anti‐bacterial and immunomodulatory effects of interferon‐γ on human neutrophils and monocytes. Immunology. 2011 Jul;133(3):329‐39. doi: 10.1111/j.1365‐2567.2011.03443.x. Epub 2011 Apr 19. 13) Pons V, Rolland C, Nauze M, Danjoux M, Gaibelet G, Durandy A, Sassolas A, Lévy E, Tercé F, Collet X, Mas E. A severe form of abetalipoproteinemia caused by new splicing mutations of microsomal triglyceride transfer protein (MTTP). Hum Mutat. 2011 Jul;32(7):751‐9.
14) Despeaux M, Labat E, Gadelorge M, Prade N, Bertrand J, Demur C, Recher C, Bonnevialle P, Payrastre B, Bourin P, Racaud‐Sultan C. Critical features of FAK‐expressing AML bone marrow microenvironment through leukemia stem cell hijacking of mesenchymal stromal cells. Leukemia 2011 Jun 7. [Epub ahead of print] 15) Boué J, Blanpied C, Brousset P, Vergnolle N, Dietrich G. Endogenous opioid‐mediated analgesia is dependent on adaptive T cell response in mice. J Immunol. 2011 May 1;186(9):5078‐84. Epub 2011 Mar 21. 16) Motta JP, Magne L, Descamps D, Rolland C, Squarzoni‐Dale C, Rousset P, Martin L, Cenac N, Balloy V, Huerre M, Fröhlich LF, Jenne D, Wartelle J, Belaaouaj A, Mas E, Vinel JP, Alric L, Chignard M, Vergnolle N, Sallenave JM. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology. 2011 Apr;140(4):1272‐82. Epub 2011 Jan 1. 17) D'Aldebert E, Cenac N, Rousset P, Martin L, Rolland C, Chapman K, Selves J, Alric L, Vinel JP, Vergnolle N. Transient receptor potential vanilloid 4 activated inflammatory signals by intestinal epithelial cells and colitis in mice. Gastroenterology. 2011 Jan;140(1):275‐85. Epub 2010 Oct 1. 18) Bourogaa E, Bertrand J, Despeaux M, Jarraya R, Fabre N, Payrastre L, Demur C, Fournié JJ, Damak M, Feki AE, Racaud‐Sultan C. Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells. Leuk Res. 2011 ; 35 : 1093‐101. Book Edition
-
N. Vergnolle and M. Chignard (eds) Proteases and their Receptors in
Inflammation, Series Progress in Inflammation Research, 1st Edition,
308 pages, DOI 10.1007/978-3-0348-0157-7_7, Springer Basel AG
2011.
Equipe 8 : Infections Virales : Persistance, réponse de l’hôte et physiopathologie (PI : Christian Davrinche et Jacques Izopet) 1) Carlier J, Martin H, Mariamé B, Rauwel B, Mengelle C, Weclawiak H, Coaquette A, Vauchy C, Rohrlich P, Kamar N, Rostaing L, Herbein G, Davrinche C.Paracrine inhibition of GM‐CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood. 2011 Oct 26. [Epub ahead of print] 2) JM. Mansuy, R. Bendall, F. Legrand‐Abravanel, K. Sauné, M. Miédougé, V. Ellis, H. Rech, F. Destruel, HR. Dalton, J. Izopet. Anti‐HEV antibodies in blood donors indicate that hepatitis E is highly endemic in South West France. Emerg Infect Dis (sous presse). 3) K. Sandres‐Sauné, S. Raymond, F. Nicot, J. Boineau, C. Pasquier, J. Izopet. Evaluation of the Qiasymphony SP and Artus RealTime Extraction‐Quantification systems for measuring HIV‐1 virus load. J Clin Virol (sous presse). 4) N. Kamar, J. Izopet, L. Rostaing. No reactivation of hepatitis E virus after kidney re‐transplantation. Am J Transplant (sous presse). 5) Ben Haij N, Mzoughi O, Planes R, Bahraoui E . Cationic nanoglycolipidic particles as vector and adjuvant for the study of the immunogenicity of SIV Nef protein. Int J Pharm 2011 ( In press). 6) Fournier T, Guibourdenche J, Handschuh K, Tsatsaris V, Rauwel B, Davrinche C, Evain‐Brion D. PPARγ and human trophoblast differentiation. J Reprod Immunol. 2011 Jun;90(1):41‐9. Epub 2011 Jun 24. 7) Lopez H, Benard M, Saint‐Aubert E, Baron M, Martin H, Al Saati T, Plantavid M, Duga‐Neulat I, Berrebi A, Cristini C, Arnaud C, Davrinche C, Davignon JL, Casper C. Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3‐dioxygenase activity. Placenta. 2011 Jul;32(7):522‐30. doi: 10.1016/j.placenta.2011.04.016. Epub 2011 May 24. 8) Mengelle C, Mansuy JM, Da Silva I, Davrinche C, Izopet J. Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood. Diagn Microbiol Infect Dis. 2011 Feb;69(2):161‐6. 9) M. Mavigner, M. Cazabat, M. Dubois, FE. L’Faqihi, M. Requena, C. Pasquier, P. Klopp, J. Amar, L. Alric, K. Barange, JP. Vinel, B. Marchou, P. Massip, J. Izopet, P. Delobel. Altered CD4+ cell homing to the gut impairs mucosal immune reconstitution in treated HIV‐infected individuals. J Clin Invest. 2011 In press. 10) Ghosn J, Galimand J, Raymond S, Meyer L, Deveau C, Goujard C, Izopet J, Rouzioux C, Chaix ML; ANRS CO 06 PRIMO cohort. X4 tropic multi‐drug resistant quasi‐species detected at the time of primary HIV‐1 infection remain exclusive or at least dominant far from PHI. PLoS One. 2011;6(8):e23301. Epub 2011 Aug 24. 11) Raymond S, Delobel P, Chaix ML, Cazabat M, Encinas S, Bruel P, Sandres‐Sauné K, Marchou B, Massip P, Izopet J. Genotypic prediction of HIV‐1 subtype D tropism. Retrovirology. 2011 Jul 13;8:56. 12) Delobel P, Saliou A, Nicot F, Dubois M, Trancart S, Tangre P, Aboulker JP, Taburet AM, Molina JM, Massip P, Marchou B, Izopet J; ANRS 106‐Window Study Team. Minor HIV‐1 variants with the K103N resistance mutation during intermittent efavirenz‐containing antiretroviral therapy and virological failure. PLoS One. 2011;6(6):e21655. Epub 2011 Jun 27. 13) Raymond S, Recordon‐Pinson P, Saliou A, Delobel P, Nicot F, Descamps D, Marcelin AG, Flandre P, Calvez V, Masquelier B, Izopet J; ANRS AC11 Resistance Study Group Improved V3 genotyping with duplicate PCR amplification for determining HIV‐1 tropism. J Antimicrob Chemother. 2011 Sep;66(9):1972‐5. Epub 2011 Jun 14. 14) Raymond S, Saliou A, Nicot F, Delobel P, Dubois M, Cazabat M, Sandres‐Sauné K, Marchou B, Massip P, Izopet J. Frequency of CXCR4‐using viruses in primary HIV‐1 infections using ultra‐deep pyrosequencing. AIDS. 2011 Aug 24;25(13):1668‐70. 15) Saliou A, Delobel P, Dubois M, Nicot F, Raymond S, Calvez V, Masquelier B, Izopet J; ANRS AC11 Resistance Study Group. Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV‐1 tropism. Antimicrob Agents Chemother. 2011 Jun;55(6):2831‐
6. Epub 2011 Apr 4. 16) Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto‐Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque‐Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011 May;140(5):1481‐9. Epub 2011 Feb 24. 17) Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N. Tenofovir therapy in hepatitis B virus‐positive solid‐organ transplant recipients. Transplantation. 2011 Apr 27;91(8):916‐20. 18) Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR. Hepatitis E virus and neurologic disorders. Emerg Infect Dis. 2011 Feb;17(2):173‐
9. Review. 19) Henquell C, Guglielmini J, Verbeeck J, Mahul A, Thibault V, Lebray P, Laperche S, Trimoulet P, Foucher J, Le Guillou‐Guillemette H, Fouchard‐Hubert I, Legrand‐Abravanel F, Métivier S, Gaudy C, D'Alteroche L, Rosenberg AR, Podevin P, Plantier JC, Riachi G, Saoudin H, Coppere H, André E, Gournay J, Feray C, Vallet S, Nousbaum JB, Baazia Y, Roulot D, Alain S, Loustaud‐Ratti V, Schvoerer E, Habersetzer F, Pérez‐Serra RJ, Gourari S, Mirand A, Odent‐Malaure H, Garraud O, Izopet J, Bommelaer G, Peigue‐Lafeuille H, van Ranst M, Abergel A, Bailly JL. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infect Genet Evol. 2011 Mar;11(2):496‐503. Epub 2011 Jan 18. 20) Laperche S, Bouchardeau F, André‐Garnier E, Thibault V, Roque‐Afonso AM, Trimoulet P, Colimon R, Duverlie G, Leguillou‐Guillemette H, Lunel F, Bouvier‐Alias M, Pawlotsky JM, Henquell C, Schvoerer E, Stoll‐Keller F, Chaix ML, Branger M, Gaudy‐Graffin C, Rosenberg AR, Pozzetto B, Vallet S, Baazia Y, Izopet J, Lefrère JJ. Interpretation of real‐time PCR results for hepatitis C virus RNA when viral load is below quantification limits. J Clin Microbiol. 2011 Mar;49(3):1113‐5. Epub 2011 Jan 12. 21) Legrand‐Abravanel F, Kamar N, Sandres‐Saune K, Lhomme S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. Hepatitis E virus infection without reactivation in solid‐organ transplant recipients, France. Emerg Infect Dis. 2011 Jan;17(1):30‐7. 22) L. Alric, D. Bonnet, O. Beynes‐Rauzy, J. Izopet, N. Kamar. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment Am J Gastroenterol 2011;106:1562‐1563. 23) A. Kenfak‐Foguena, F. Schöni‐Affolter, P. Bürgisser, A. Witteck, KEA. Darling, H. Kovari, L. Kaiser, JM. Evison, L. Elzi, V. Gurtner‐De La Fuente, J. Jost, D. Moradpour, F. Abravanel, J. Izopet, M. Cavassini and the Swiss HIV Cohort Study. Hepatitis E virus seroprevalence and chronic infection in patients with HIV. Emerg Infect Dis 2011;17:1074‐1078. 24) JM. Péron, H. Dalton, J. Izopet, K. Nassim. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin. J Hepatol 2011;54:1323‐1324. 25) L. Alric, D. Bonnet, F. Legrand‐Abravanel, JM. Mansuy, G. Laurent, N. Kamar, J. Izopet. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon‐alpha therapy. Ann Intern Med 2011;153:135‐136. 26) ) Champagne, E. ‐T cell receptor ligands and modes of antigen recognition. Arch Immunol Ther Exp (Warsz). 2011 Jan 59, 117‐137. Equipe 9 : Physiopathologie des infections persistantes du système nerveux central (PI : Daniel Dunia) Chevalier G, Suberbielle E, Monnet C, Duplan V, Martin‐Blondel G, Farrugia F, Le Masson G, Liblau R, Gonzalez‐Dunia D. Neurons are MHC Class I‐Dependent Targets for CD8 T Cells upon Neurotropic Viral Infection. PLoS Pathog. 2011 Nov;7(11):e1002393. Epub 2011 Nov 17. Equipe 10 : Appretement des Antigenes au cours de l’immunité anti‐
parasitaire (PI : Nicolas Blanchard) 1)Cebrian I, Visentin G, Blanchard N, Jouve M, Bobard A, Moita C, Enninga J, Moita LF, Amigorena S, Savina A. Sec22b controls both the recruitment of ER‐resident proteins to phagosomes and antigen cross‐presentation in dendritic cells. Cell 2011 (in press) Equipe 11 : Pathogene moléculaire et cellulaire des infections a Escherichia coli ( PI : Eric Oswald) 1)Valat C, Haenni M, Saras E, Auvray F, Forest K, Oswald E, Madec JY First report of CTX‐M‐15 Extended‐Spectrum β‐Lactamase in a Shiga toxin‐producing Escherichia coli (STEC) of serogroup O111:H8. Appl Environ Microbiol. 2011 Dec 9. 2) Dubois D, Baron O, Cougnoux A, Delmas J, Pradel N, Boury M, Bouchon B, Bringer MA, Nougayrède JP, Oswald E, Bonnet R.ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides.J Biol Chem. 2011 Oct 14;286(41):35562‐70. Epub 2011 Jul 27. 3) Krieger JN, Dobrindt U, Riley DE, Oswald E.Acute Escherichia coli prostatitis in previously health young men: bacterial virulence factors, antimicrobial resistance, and clinical outcomes.Urology. 2011 Jun;77(6):1420‐5. Epub 2011 Apr 3. 4 )Madic J, de Garam CP, Brugère H, Loukiadis E, Fach P, Jamet E, Auvray F.Duplex real‐time PCR detection of type III effector tccP and tccP2 genes in pathogenic Escherichia coli and prevalence in raw milk cheeses.Lett Appl Microbiol. 2011 May;52(5):538‐45. doi: 10.1111/j.1472‐
765X.2011.03038.x. Epub 2011 Mar 21. 5) Clermont O, Olier M, Hoede C, Diancourt L, Brisse S, Keroudean M, Glodt J, Picard B, Oswald E, Denamur E.Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol. 2011 Apr;11(3):654‐62. Epub 2011 Feb 13. 6) Taieb F, Nougayrède JP, Oswald E.Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin‐dependent degradation pathway of host cells.Toxins (Basel). 2011 Apr;3(4):356‐68. Epub 2011 Mar 29. 7 )Madic J, Vingadassalon N, de Garam CP, Marault M, Scheutz F, Brugère H, Jamet E, Auvray F Detection of Shiga toxin‐producing Escherichia coli serotypes O26:H11, O103:H2, O111:H8, O145:H28, and O157:H7 in raw‐milk cheeses by using multiplex real‐time PCR. Appl Environ Microbiol. 2011 Mar;77(6):2035‐41. Epub 2011 Jan 14. Equipe 12 : Mécanismes moléculaires de la croissance, de l’osteogenese et de l’osteolyse, biotherapies ( PI : JP Salles) 1)Pont F, Familiades J, Déjean S, Fruchon S, Cendron D, Poupot M, Poupot R, L’Faqihi‐Olive F, Prade N, Ycart B & Fournié JJ.The gene expression profile of phosphoantigen‐specific human T lymphocytes is a blend of T cell and NK cell signatures. Eur. J. Immunol. 41 : sous presse 2)Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost. 2011 Oct;9(10):1883‐91. doi: 10.1111/j.1538‐
7836.2011.04478. 3)Kémoun P, Gronthos S, Snead ML, Rue J, Courtois B, Vaysse F, Salles JP, Brunel G. The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro. Biomaterials. 2011 Oct;32(30):7375‐88. Epub 2011 Jul 23. 4)De Cock VC, Diene G, Molinas C, Masson VD, Kieffer I, Mimoun E, Tiberge M, Tauber M. Efficacy of modafinil on excessive daytime sleepiness in Prader‐Willi syndrome. Am J Med Genet A. 2011 Jul;155A(7):1552‐7. doi: 10.1002/ajmg.a.34047. 5)Tauber M, Mantoulan C, Copet P, Jauregui J, Demeer G, Diene G, Rogé B, Laurier V, Ehlinger V, Arnaud C, Molinas C, Thuilleaux D. Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader‐Willi syndrome: a randomised placebo‐controlled trial in 24 patients.Orphanet J Rare Dis. 2011 Jun 24;6(1):47. 6)Gennero I, Laurencin‐Dalicieux S, Conte‐Auriol F, Briand‐Mésange F, Laurencin D, Rue J, Beton N, Malet N, Mus M, Tokumura A, Bourin P, Vico L, Brunel G, Oreffo RO, Chun J, Salles JP. Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone. 2011 Sep;49(3):395‐403. Epub 2011 May 1. 7)Courties G., Baron M., Presumey J., Escriou V., Van Lent P., Scherman D., Cantagrel A., Van den Berg W., Jorgensen C., Apparailly F. and DavignonJ‐L. Cytosolic Phospholipase A2α Gene Silencing in the Myeloid Lineage Alters Development of Th1 Responses and Reduces Autoimmune Arthritis Arthritis Rheumatism, 2011 Mar;63(3):681‐90. 8)Hayder M., M. Poupot, M. Baron, D. Nigon, C‐O Turrin, A‐M Caminade, J‐P Majoral, J‐J Fournié, A Cantagrel, R. Poupot and J‐L Davignon Phosphorus‐based dendrimer as nanotherapeutics targeting both inflammation and osteoclastogenesis in experimental arthritis. 2011. Science Translational Medicine, 3, 81ra35. 9)Jouret B, Dulac Y, Bassil Eter R, Taktak A, Cristini C, Lounis N, Molinas C, Salles JP, Arnaud C, Acar P, Tauber M.Endothelial function and mechanical arterial properties in children born small for gestational age: comparison with obese children.Horm Res Paediatr. 2011;76(4):240‐7. Epub 2011 Sep 7. 10)Hélène Lopez; Mélinda Bénard; Emmylou Saint‐Aubert; Michel Baron; Hélène Martin; Talal Al Saati; Monique Plantavid; Isabelle Duga‐Neulat; Alain Berrebi; Christelle Cristini; Catherine Arnaud; Christian Davrinche; Jean‐Luc Davignon, Charlotte Casper. Novel Model of Placental Tissue Explants Infected by Cytomegalovirus Reveals Different Permissiveness in Early and Term Placentae and Inhibition of Indoleamine 2,3‐Dioxygenase Activity. Placenta, 2011; 522‐530. 11)Jean‐Frédéric Boyer, Pierre Antoine Gourraud, Alain Cantagrel, Jean Luc Davignon, Arnaud Constantin Traditional cardiovascular risk factors in rheumatoid arthritis: a meta‐analysis. Joint Bone Spine, 2011;78(2):179‐83. 12)Hayder M, Fruchon S, Fournié JJ, Poupot M & Poupot R (2011) Anti‐inflammatory properties of dendrimers per se. Scientific World Journal, 11 : 1367‐1382. Dauguet N, Recher C, Demur C, Fournié JJ, Poupot M & Poupot R (2011) Pre‐eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission. Am. J. Hematol. 86 : 209‐213. Equipe 14 : Fer, Génétique et Biologie Intégrative (PI : Marie‐Paule Roth, Hélène Coppin) 1) Hadziahmetovic M, Song Y, Wolkow N, Iacovelli J, Kautz L, Roth MP, Dunaief JL. Bmp6 regulates retinal iron homeostasis and has altered expression in age‐related macular degeneration. Am J Pathol. 2011 Jul;179(1):335‐48. Epub 2011 May 3. 2) Allanore Y, Saad M, Dieudé P, Avouac J, Distler JH, Amouyel P, Matucci‐Cerinic M, Riemekasten G, Airo P, Melchers I, Hachulla E, Cusi D, Wichmann HE, Wipff J, Lambert JC, Hunzelmann N, Tiev K, Caramaschi P, Diot E, Kowal‐Bielecka O, Valentini G, Mouthon L, Czirják L, Damjanov N, Salvi E, Conti C, Müller M, Müller‐Ladner U, Riccieri V, Ruiz B, Cracowski JL, Letenneur L, Dupuy AM, Meyer O, Kahan A, Munnich A, Boileau C, Martinez M. Genome‐wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 2011 Jul;7(7):e1002091. 3) Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y, Chalès G, Loréal O, Chappard D. Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int. 2011 Aug;22(8):2313‐
9. Epub 2010 Oct 26 4) Plagnol V, Nalls MA, Bras JM, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simón‐Sánchez J, Schulte C, Lesage S, Sveinbjörnsdóttir S, Amouyel P, Arepalli S, Band G, Barker RA, Bellinguez C, Ben‐
Shlomo Y, Berendse HW, Berg D, Bhatia K, de Bie RM, Biffi A, Bloem B, Bochdanovits Z, Bonin M, Brockmann K, Brooks J, Burn DJ, Charlesworth G, Chen H, Chinnery PF, Chong S, Clarke CE, Cookson MR, Cooper JM, Corvol JC, Counsell C, Damier P, Dartigues JF, Deloukas P, Deuschl G, Dexter DT, van Dijk KD, Dillman A, Durif F, Dürr A, Edkins S, Evans JR, Foltynie T, Freeman C, Gao J, Gardner M, Gibbs JR, Goate A, Gray E, Guerreiro R, Gústafsson Ó, Harris C, Hellenthal G, van Hilten JJ, Hofman A, Hollenbeck A, Holton J, Hu M, Huang X, Huber H, Hudson G, Hunt SE, Huttenlocher J, Illig T, Jónsson PV, Langford C, Lees A, Lichtner P, Limousin P, Lopez G, Lorenz D, McNeill A, Moorby C, Moore M, Morris H, Morrison KE, Mudanohwo E, O'Sullivan SS, Pearson J, Pearson R, Perlmutter JS, Pétursson H, Pirinen M, Pollak P, Post B, Potter S, Ravina B, Revesz T, Riess O, Rivadeneira F, Rizzu P, Ryten M, Sawcer S, Schapira A, Scheffer H, Shaw K, Shoulson I, Sidransky E, de Silva R, Smith C, Spencer CC, Stefánsson H, Steinberg S, Stockton JD, Strange A, Su Z, Talbot K, Tanner CM, Tashakkori‐Ghanbaria A, Tison F, Trabzuni D, Traynor BJ, Uitterlinden AG, Vandrovcova J, Velseboer D, Vidailhet M, Vukcevic D, Walker R, van de Warrenburg B, Weale ME, Wickremaratchi M, Williams N, Williams‐
Gray CH, Winder‐Rhodes S, Stefánsson K, Martinez M, Donnelly P, Singleton AB, Hardy J, Heutink P, Brice A, Gasser T, Wood NW. A two‐stage meta‐analysis identifies several new loci for Parkinson's disease. PLoS Genet. 2011 Jun;7(6):e1002142. Epub 2011 Jun 30. 5) Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, Ginzburg Y, Roth MP, Nemeth E, Ganz T. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology. 2011 Apr;53(4):1333‐41. doi: 10.1002/hep.24178. 6) International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simón‐Sánchez J, Schulte C, Lesage S, Sveinbjörnsdóttir S, Stefánsson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta‐analysis of genome‐wide association studies. Lancet. 2011 Feb 19;377(9766):641‐9. 7) Kautz L, Besson‐Fournier C, Meynard D, Latour C, Roth MP, Coppin H. Iron overload induces BMP6 expression in the liver but not in the duodenum. Haematologica. 2011 Feb;96(2):199‐203. Epub 2010 Oct 15. 8) Saad M, Lesage S, Saint‐Pierre A, Corvol JC, Zelenika D, Lambert JC, Vidailhet M, Mellick GD, Lohmann E, Durif F, Pollak P, Damier P, Tison F, Silburn PA, Tzourio C, Forlani S, Loriot MA, Giroud M, Helmer C, Portet F, Amouyel P, Lathrop M, Elbaz A, Durr A, Martinez M, Brice A; French Parkinson's Disease Genetics Study Group Genome‐wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.. Hum Mol Genet. 2011 Feb 1;20(3):615‐27. Epub 2010 Nov 17.
9) Lenoir A, Deschemin JC, Kautz L, Ramsay AJ, Roth MP, Lopez‐Otin C, Vaulont S, Nicolas G. Iron‐
deficiency anemia from matriptase‐2 inactivation is dependent on the presence of functional Bmp6. Blood. 2011 Jan 13;117(2):647‐50. Epub 2010 Oct 12. Equipe 14 : Biologie des Lymphocytes T CD4 Folliculaires (PI :Nicolas Fazilleau)
1) A. Lehuen & N. Fazilleau. Innate iNKT cell help to B cells: Fast but does not last. Nature Immunol. (News and Views). 2011 In press. 2) Viret C, Lamare C, Guiraud M, Fazilleau N, Bour A, Malissen B, Carrier A, Guerder S. Thymus‐
specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire. J Exp Med. 2011 Jan 17;208(1):3‐11. Epub 2010 Dec 20. 3) Pomié C, Vicente R, Vuddamalay Y, Lundgren BA, van der Hoek M, Enault G, Kagan J, Fazilleau N, Scott HS, Romagnoli P, van Meerwijk JP. Autoimmune regulator (AIRE)‐deficient CD8+CD28low regulatory T lymphocytes fail to control experimental colitis. Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12437‐42. Epub 2011 Jul 11.